Related Experiment Video
Updated: Mar 16, 2026
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Management of acute viral bronchiolitis in children: Evidence beyond guidelines
1Department of Pediatrics , College of Medicine, King Saud University, Riyadh , Saudi Arabia.
Insights
Acute viral bronchiolitis, a common childhood illness, lacks a clear definition, leading to varied treatments. Prevention through immunoprophylaxis is key for reducing severe cases in high-risk infants.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Acute viral bronchiolitis is a major cause of hospitalization for young children globally.
- Inconsistent clinical definitions contribute to varied management strategies worldwide.
Purpose of the Study:
- To review the epidemiology, etiology, risk factors, pathophysiology, clinical presentation, assessment, and management of respiratory syncytial virus (RSV) bronchiolitis in children.
Main Methods:
- Systematic review of worldwide literature on RSV bronchiolitis.
Main Results:
- Supportive and symptomatic care remains the primary treatment approach.
- Immunoprophylaxis is crucial for preventing infection, especially in high-risk children.
Conclusions:
- Standardized definitions and preventative measures are needed for effective bronchiolitis management.
- Reducing morbidity and mortality hinges on infection prevention and immunoprophylaxis for vulnerable infants.
Abstract:
Acute viral bronchiolitis is one of the leading causes of worldwide admission of children under 2 years of age during winter months. There is a lack of consensus regarding the clinical definition of acute viral bronchiolitis in children and hence the management varies across the globe. The purpose of this article is to review the epidemiology, etiology, risk factors, pathophysiology, clinical presentation, assessment and management of children with respiratory syncytial virus (RSV) bronchiolitis. The available evidence in the worldwide literature suggests that supportive and symptomatic management is still the mainstay of management in this condition. The key to reducing the morbidity and mortality in children with RSV bronchiolitis is through prevention of infection through immunoprophylaxis especially in high-risk children.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:26Tonsillitis II: Management
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.